Published Date: 02 Mar 2023
You may not have heard of respiratory syncytial virus (RSV). However, it killed more than 100,000 people worldwide in 2019, making it the leading cause of death among children under the age of one.
Read Full NewsPatients with breast cancer living in states with expanded Medicaid eligibility, have seen survival gains, raising more concerns about the impact of recent changes to the program.
The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.
Therapeutic vaccines are advancing in oncology and HIV, with the aim of retraining immune responses to target tumors and persistent viral reservoirs with precision.
Ten-year survival data support salvage focal therapy as an option for patients with localized recurrence after prostate cancer radiotherapy.
Researchers asked more than 2000 women if they preferred at-home vaginal self-sampling over clinic-based testing to screen for cervical cancer.
‘Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.
Researchers compared outcomes of stereotactic radiation and hippocampal-avoidance whole brain radiation in patients with 5-20 brain metastases.
1.
Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL
2.
Some triple negative breast cancers might be avoided by longer breastfeeding
3.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
4.
How Do Younger People Fare With Stool Tests for CRC Screening?
5.
Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer
1.
Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health
2.
Unveiling the Hidden Mechanisms of Hemolytic Reactions
3.
Unlocking the Mystery of Leukemia: Exploring New Treatments and Hope for Patients
4.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
5.
An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part I
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation